Brief: Relay Therapeutics Reports Fourth Quarter And Full Year 2022 Financial Results And Corporate Highlights
24/02/2023 24:09
Feb 23 (Reuters) - Relay Therapeutics Inc RLAY.O :
* RELAY THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS
* RELAY THERAPEUTICS INC - APPROXIMATELY $1 BILLION IN CASH,
CASH
EQUIVALENTS AND INVESTMENTS AT END OF 2022, EXPECTED TO FUND
OPERATIONS INTO 2025
* RELAY THERAPEUTICS INC - QTRLY LOSS PER SHARE $0.56
Source text for Eikon: ID:nGNX87KMLq
Further company coverage: RLAY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Relay Therapeutics
See all newsBrief: X-Chem Announces Phase 3 Milestone In Collaboration With Relay Therapeutics
Relay Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Relay Therapeutics Q2 revenue misses estimates on higher R&D expenses; net loss widens
Brief: Relay Therapeutics Q2 Net Income USD -83.707 Million Vs. IBES Estimate USD -74.2 Million
U.S. RESEARCH ROUNDUP- Alliant Energy, Prog Holdings, Travelers